MX340539B - Base de minociclina cristalina y procesos para su preparacion. - Google Patents

Base de minociclina cristalina y procesos para su preparacion.

Info

Publication number
MX340539B
MX340539B MX2012005474A MX2012005474A MX340539B MX 340539 B MX340539 B MX 340539B MX 2012005474 A MX2012005474 A MX 2012005474A MX 2012005474 A MX2012005474 A MX 2012005474A MX 340539 B MX340539 B MX 340539B
Authority
MX
Mexico
Prior art keywords
minocycline base
processes
preparation
crystalline
crystalline minocycline
Prior art date
Application number
MX2012005474A
Other languages
English (en)
Inventor
Heggie William
Mendes Zita
Rafael Antunes Jose
Marto Susana
Original Assignee
Hovione Scientia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hovione Scientia Ltd filed Critical Hovione Scientia Ltd
Publication of MX340539B publication Critical patent/MX340539B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una base de minociclina cristalina. En particular, se proporcionan tres formas polimórficas cristalinas, designadas Forma I, Forma II y Forma III, de base de minociclina. Son caracterizadas por datos de XRD e IR. También se proporcionan procesos para preparar las nuevas formas polimórficas. Por ejemplo, la Forma I se prepara por disolución y/o suspensión de la base de minociclina amorfa en un solvente orgánico elegido de éteres seguido por cristalización de la mezcla.
MX2012005474A 2007-02-23 2009-08-21 Base de minociclina cristalina y procesos para su preparacion. MX340539B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT103661A PT103661B (pt) 2007-02-23 2007-02-23 Processo de preparação de minociclina base cristalina

Publications (1)

Publication Number Publication Date
MX340539B true MX340539B (es) 2016-07-13

Family

ID=39432804

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2009008980A MX2009008980A (es) 2007-02-23 2008-02-22 Base de minociclina cristalina y procesos para su preparacion.
MX2012005474A MX340539B (es) 2007-02-23 2009-08-21 Base de minociclina cristalina y procesos para su preparacion.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2009008980A MX2009008980A (es) 2007-02-23 2008-02-22 Base de minociclina cristalina y procesos para su preparacion.

Country Status (20)

Country Link
US (2) US8258327B2 (es)
EP (1) EP2125705B1 (es)
JP (4) JP2010519247A (es)
KR (1) KR101391132B1 (es)
CN (1) CN101679218B (es)
AU (1) AU2008217619B2 (es)
BR (2) BRPI0807319B1 (es)
CA (2) CA2835788C (es)
DK (1) DK2125705T3 (es)
ES (1) ES2610434T3 (es)
HU (1) HUE033030T2 (es)
IL (1) IL200544A0 (es)
MX (2) MX2009008980A (es)
NO (1) NO20092960L (es)
NZ (1) NZ579626A (es)
PL (1) PL2125705T3 (es)
PT (1) PT103661B (es)
RU (2) RU2577331C2 (es)
WO (1) WO2008102161A2 (es)
ZA (1) ZA200906517B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
NZ540166A (en) 2002-10-25 2007-06-29 Foamix Ltd Cosmetic and pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
PT103661B (pt) 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
PT104350A (pt) * 2009-01-23 2010-07-23 Hovione Farmaci Ncia S A Processo de isolamento de tigeciclina
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
PT104644B (pt) 2009-06-26 2012-11-06 Hovione Farmaciencia S A Formulação tópica contendo uma tetraciclina e método de tratamento de infecções cutâneas usando a mesma
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8945516B2 (en) 2009-10-02 2015-02-03 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
PT106063B (pt) 2011-12-19 2017-05-30 Inst Superior Tecnico Minociclina cristalina termorresistente produzida por recristalização com dióxido de carbono
CN104151186B (zh) * 2014-08-11 2016-06-15 重庆福安药业(集团)股份有限公司 替加环素杂质的立体选择性制备方法
PT108223B (pt) * 2015-02-13 2018-05-08 Hovione Farm S A Novas formas polimórficas de minociclina base e processos para a sua preparação
CA2980527A1 (en) 2015-03-23 2016-09-29 BioPharmX, Inc. Pharmaceutical tetracycline composition for dermatological use
WO2017097891A1 (en) * 2015-12-10 2017-06-15 Sandoz Ag Crystalline eravacycline
MX2017011630A (es) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Composiciones y metodos para tratar rosacea y acne.
WO2021191273A1 (en) 2020-03-24 2021-09-30 Hovione Scientia Limited Compositions for use in treating meibomian gland dysfunction
US20220062308A1 (en) 2020-08-27 2022-03-03 Hovione Scientia Limited Methods and compositions for treating rosacea

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US299111A (en) * 1884-05-27 Process of and apparatus
US3148212A (en) 1961-12-22 1964-09-08 American Cyanamid Co Reductive alkylation process
USRE26253E (en) 1963-05-17 1967-08-15 And z-alkylamino-g-deoxytetracycline
US3526629A (en) * 1968-04-02 1970-09-01 American Cyanamid Co Beta-hydroxyethylpiperazinocarboxymethyl - 7 - dimethylamino - 6 - deoxy-6-demethyltetracycline
JPS5245716B1 (es) * 1970-07-10 1977-11-17
NL158172B (nl) * 1972-09-18 1978-10-16 Farmaceutici Italia Werkwijze voor het bereiden van tetracyclinederivaten met een substituent op de 7-plaats.
CN85101404A (zh) * 1985-05-16 1987-01-17 帝人株式会社 头孢菌素衍生物的生产过程
JPH0737433B2 (ja) 1987-06-11 1995-04-26 協和醗酵工業株式会社 ７−アミノ−６−デメチル−６−デオキシテトラサイクリンの製造法
US4918208A (en) * 1987-07-28 1990-04-17 Nippon Kayaku Kabushiki Kaisha Process for producing 7-dimethylamino-6-demethyl-6-deoxytetracycline
US5202449A (en) * 1987-07-28 1993-04-13 Nippon Kayaku Kabushiki Kaisha Process for purifying 7-dimethylamino-6-demethyl-6-deoxytetracycline
JPH04235188A (ja) * 1990-06-19 1992-08-24 Takeda Chem Ind Ltd ペネム化合物の結晶、その製造方法および抗菌剤
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline
DE4235133A1 (de) * 1992-10-19 1994-04-21 Bayer Ag Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
JP3623531B2 (ja) * 1993-06-07 2005-02-23 ビーエーエスエフ アクチェンゲゼルシャフト 結晶質ｌ−アスコルビン酸−２−燐酸エステルマグネシウム塩の製造法
ATE284868T1 (de) * 1995-07-17 2005-01-15 Warner Lambert Co Kristaline (r-(r*,r*))-2-(4-fluorphenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- ((phenylamino)carbonyl)-1h-pyrrol-1- heptancarbonsäure hemi calcium sslz (atorvastatin)
JP2001526227A (ja) 1997-12-22 2001-12-18 シェーリング コーポレイション バイオアベイラビリティーを高めた分子分散組成物
IE991013A1 (en) * 1998-12-01 2000-07-12 Atropos Ltd A Device
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
AR057649A1 (es) * 2005-05-27 2007-12-12 Wyeth Corp Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
JP2009502809A (ja) * 2005-07-21 2009-01-29 パラテック ファーマシューティカルズ インコーポレイテッド １０−置換テトラサイクリンおよびその使用方法
PT103661B (pt) 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina

Also Published As

Publication number Publication date
RU2009135403A (ru) 2011-03-27
JP2010519247A (ja) 2010-06-03
US20130030195A1 (en) 2013-01-31
JP2017039742A (ja) 2017-02-23
RU2485095C2 (ru) 2013-06-20
AU2008217619A1 (en) 2008-08-28
ZA200906517B (en) 2010-09-29
PL2125705T3 (pl) 2017-02-28
KR20100014520A (ko) 2010-02-10
CA2722496A1 (en) 2008-08-28
WO2008102161A2 (en) 2008-08-28
PT103661A (pt) 2008-08-25
NO20092960L (no) 2009-11-20
BR122021000846B1 (pt) 2021-08-10
MX2009008980A (es) 2009-11-11
RU2577331C2 (ru) 2016-03-20
EP2125705B1 (en) 2016-10-12
CA2835788C (en) 2018-03-27
RU2013112021A (ru) 2014-09-27
BRPI0807319A2 (pt) 2017-05-02
CN101679218A (zh) 2010-03-24
CA2835788A1 (en) 2008-08-28
BRPI0807319B1 (pt) 2021-08-10
US20100286417A1 (en) 2010-11-11
CN101679218B (zh) 2013-10-30
JP2019142882A (ja) 2019-08-29
US9416097B2 (en) 2016-08-16
EP2125705A2 (en) 2009-12-02
HUE033030T2 (hu) 2017-11-28
JP2014169319A (ja) 2014-09-18
KR101391132B1 (ko) 2014-05-02
AU2008217619B2 (en) 2013-01-10
NZ579626A (en) 2011-12-22
ES2610434T3 (es) 2017-04-27
DK2125705T3 (en) 2017-01-16
PT103661B (pt) 2010-09-07
IL200544A0 (en) 2010-05-17
CA2722496C (en) 2014-06-10
WO2008102161A9 (en) 2008-11-13
WO2008102161A3 (en) 2009-01-08
US8258327B2 (en) 2012-09-04

Similar Documents

Publication Publication Date Title
MX340539B (es) Base de minociclina cristalina y procesos para su preparacion.
WO2007136510A3 (en) Polymorphic forms of imatinib mesylate and processes for their preparation as well as of amorphous imatinib mesylate and form alpha
AU2015221439B2 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same
WO2006027705A3 (en) Synthesis of triethylenetetramines
WO2009006590A3 (en) Docetaxel process and polymorphs
WO2009053854A3 (en) Polymorphs of dasatinib and process for preparation thereof
MX2009001067A (es) Formas cristalinas de analogos de rapamicina.
MX2010003155A (es) Derivados de ciclopropil aril amida y uso de los mismos.
WO2004082619A3 (en) Forms of 5-azacytidine
MX2010002836A (es) Bortezomib y proceso para la produccion del mismo.
MX2009008540A (es) Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina.
UA102787C2 (ru) Способ приготовления кристаллических форм а и в илапразола и способ преобразования кристаллических форм
WO2008021342A3 (en) Amorphous and crystalline forms of 9-hydroxy-risperidone ( paliperidone )
TN2011000326A1 (en) Quinazolinone derivatives useful as vanilloid antagonits
WO2007081907A3 (en) Crystalline forms of dolasetron base and processes for preparation thereof
WO2008155666A3 (en) Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
NZ594010A (en) Novel forms of bendamustine free base
GB0516603D0 (en) Processes for the preparation of organic compounds useful as serotonin receptor antagonists
WO2007003200A3 (en) High yield synthesis methods for producing organic salts of strontium
MX2012006524A (es) Proceso para la sintesis de compuestos intermedios de utilidad para preparar compuestos sustituidos de indazol y azaindol.
WO2010027848A3 (en) Forms of lapatinib compounds and processes for the preparation thereof
MX2013006658A (es) Métodos para producir y usar brasinoesteroides para promover el crecimiento, la reparación y mantenimiento del músculo esquelético y la piel.
WO2009021943A3 (de) Neues herstellverfahren
WO2010140132A8 (en) Process for the preparation of crystalline aprepitant having form i content
MX2010003056A (es) Polimorfos de valomaciclovir.